Boston Scientific Corporation mismanagement caused the company’s shares to drop 12.6 percent and eliminate about $1.5 billion in market value, investors claim in Massachusetts Federal Court.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

